Search Results

Study: TEVAR More Cost-Effective Than Open Repair of Acute Complicated Type B Aortic Dissections

May 7, 2014—Thomas Luebke, MD, and Jan Brunkwall, MD, published findings from a study of the cost-effectiveness of thoracic endovascular aortic repair (TEVAR) versus open repair (OR) of acute complicated type B aortic dissections (TBAD) in the Journal of Vascular Surgery (2014;59:1247–1255).

Cordis Incraft System Studied in INNOVATION

April 11, 2010—Cordis Corporation (Bridgewater, NJ) announced that the first patients have been enrolled in the INNOVATION trial, which will assess the safety of the company's new Incraft stent graft system to treat abdominal aortic aneurysms (AAAs).

Jotec's E-liac Stent Graft System Approved in Europe

January 24, 2014—Jotec GmbH (Hechingen, Germany) announced that the company’s E-liac stent graft system has received European CE Mark approval.

Cordis Commences INNOVATION Trial of Very Low-Profile Incraft System to Treat AAA

April 11, 2010—Cordis Corporation (Bridgewater, NJ) announced that the first patients have been enrolled in the INNOVATION trial, which will assess the safety of the company's new Incraft stent graft system to treat abdominal aortic aneurysms (AAA).

Enrollment Continues in Postmarket Registry for Jotec's E-liac System

April 17, 2015—Jotec GmbH announced continuing enrollment in the PLIANT postmarket registry of the company’s new-generation, low-profile E-liac stent graft system in patients with iliac aneurysm undergoing endovascular stent treatment.

Enrollment Completed for European PLIANT Registry of Jotec's E-liac Stent Graft System

June 27, 2016—Jotec GmbH announced completion of patient enrollment of the PLIANT postmarket registry.

Jotec Commences PLIANT Postmarket Registry

August 7, 2014—Jotec GmbH announced the initiation of the PLIANT postmarket registry of the company’s new-generation, low-profile E-liac stent graft system in patients with iliac aneurysm undergoing endovascular stent treatment.